Profil
Olav Steinnes is currently the Director at Ostomycure AS, ProfMOF AS, CardiNor AS, Prosa Security AS, and Orphan Diagnostics AS.
He is also the Chief Financial Officer at Inven2 AS since 2011.
Previously, he held positions as Chairman at Qotics AS and Serca Pharmaceuticals AS.
He was also the Managing Director at Axis-Shield Ltd. and Director at Mole Genetics AS, NeoRad AS, Cgene AS, Medinnova AS, Serodus ASA, Nordic Nanovector ASA, Zelluna Immunotherapy AS, and Vice President-Diagnostics at Takeda AS.
Mr. Steinnes graduated from the Norwegian School of Economics & Business Administration.
Postes actifs de Olav Steinnes
| Sociétés | Poste | Début |
|---|---|---|
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 invests in technology based companies located in Norway. The firm targets companies operating in the fields of a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Directeur Financier/CFO | 01/01/2011 |
Ostomycure AS
Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Develops solution for evacuating of fluids from the intestines | Directeur/Membre du Conseil | - |
ProfMOF AS
ProfMOF AS Miscellaneous Commercial ServicesCommercial Services Provides metal organic frameworks | Directeur/Membre du Conseil | - |
CardiNor AS
CardiNor AS BiotechnologyHealth Technology Develops, produces and sells in-vitro diagnostic products | Directeur/Membre du Conseil | - |
Prosa Security AS
Prosa Security AS Packaged SoftwareTechnology Services Develops cyber security software | Directeur/Membre du Conseil | - |
Orphan Diagnostics AS
Orphan Diagnostics AS Medical SpecialtiesHealth Technology Develops diagnostic tools | Directeur/Membre du Conseil | - |
Anciens postes connus de Olav Steinnes
| Sociétés | Poste | Fin |
|---|---|---|
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Manufactures and sells instruments & pre-filled reagent cartridges for genetic research | Directeur/Membre du Conseil | 31/05/2012 |
Medinnova AS
Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees. | President | 01/01/2011 |
| AXIS-SHIELD LTD | Directeur Général | 31/12/2007 |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Olav Steinnes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Axis-Shield Ltd.
Axis-Shield Ltd. Medical SpecialtiesHealth Technology Manufactures and designs vitro diagnostic products for use in the laboratory | Health Technology |
Takeda AS
Takeda AS Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic medicines | Health Technology |
Norwegian School of Economics & Business Administration
Norwegian School of Economics & Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Manufactures and sells instruments & pre-filled reagent cartridges for genetic research | Health Technology |
NeoRad AS
NeoRad AS Medical SpecialtiesHealth Technology Creates products for medical procedures | Health Technology |
Cgene AS
Cgene AS Miscellaneous Commercial ServicesCommercial Services Offers contract-based research within the field of in vivo molecular imaging | Commercial Services |
Medinnova AS
Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees. | Finance |
Ostomycure AS
Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Develops solution for evacuating of fluids from the intestines | Commercial Services |
Serodus ASA
Serodus ASA BiotechnologyHealth Technology Develops drugs and diabetic comorbidities | Health Technology |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 invests in technology based companies located in Norway. The firm targets companies operating in the fields of a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Qotics AS
Qotics AS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
ProfMOF AS
ProfMOF AS Miscellaneous Commercial ServicesCommercial Services Provides metal organic frameworks | Commercial Services |
CardiNor AS
CardiNor AS BiotechnologyHealth Technology Develops, produces and sells in-vitro diagnostic products | Health Technology |
Prosa Security AS
Prosa Security AS Packaged SoftwareTechnology Services Develops cyber security software | Technology Services |
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies | Health Technology |
Orphan Diagnostics AS
Orphan Diagnostics AS Medical SpecialtiesHealth Technology Develops diagnostic tools | Health Technology |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Develops drug treatment products for injuries | Health Technology |
















